NO135939C - - Google Patents

Info

Publication number
NO135939C
NO135939C NO2395/70A NO239570A NO135939C NO 135939 C NO135939 C NO 135939C NO 2395/70 A NO2395/70 A NO 2395/70A NO 239570 A NO239570 A NO 239570A NO 135939 C NO135939 C NO 135939C
Authority
NO
Norway
Application number
NO2395/70A
Other languages
Norwegian (no)
Other versions
NO135939B (en:Method
Inventor
S A Lee
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5013069A external-priority patent/GB1260886A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Priority to NO762973A priority Critical patent/NO137124C/no
Publication of NO135939B publication Critical patent/NO135939B/no
Publication of NO135939C publication Critical patent/NO135939C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Monitoring And Testing Of Nuclear Reactors (AREA)
NO2395/70A 1969-06-20 1970-06-19 NO135939C (en:Method)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO762973A NO137124C (no) 1969-06-20 1976-08-30 Fremgangsm}te for fremstilling av morfolinderivater

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3125569 1969-06-20
GB5013069A GB1260886A (en) 1969-06-20 1969-06-20 Process for aryloxymethylmorpholine derivatives

Publications (2)

Publication Number Publication Date
NO135939B NO135939B (en:Method) 1977-03-21
NO135939C true NO135939C (en:Method) 1977-07-06

Family

ID=26260810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2395/70A NO135939C (en:Method) 1969-06-20 1970-06-19

Country Status (9)

Country Link
US (1) US3712890A (en:Method)
JP (1) JPS5016795B1 (en:Method)
CH (1) CH539068A (en:Method)
ES (1) ES380973A1 (en:Method)
FI (1) FI61890C (en:Method)
HU (1) HU162422B (en:Method)
NO (1) NO135939C (en:Method)
SE (1) SE393377B (en:Method)
YU (2) YU35009B (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857839A (en) * 1969-06-20 1974-12-31 Ici Ltd For cyclising 1-aryloxy-3 beta-substituted ethylamino-2-propanols
GB1427097A (en) * 1973-10-18 1976-03-03 Ici Ltd Optically-active morpholine derivatives
JPS5939437B2 (ja) * 1975-05-08 1984-09-22 ウェルファイド株式会社 モルホリン誘導体の製造法
JPS51146900U (en:Method) * 1975-05-20 1976-11-25
US4005084A (en) * 1975-07-10 1977-01-25 Yoshitomi Pharmaceutical Industries, Ltd. Thienylmethyl phenoxy morpholine compounds
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4351848A (en) * 1978-03-16 1982-09-28 Drug Science Foundation 1-((1-Methylethyl)amino)-3-(((4-alkylthio)1-naphthalenyl)oxy)-2-propanol
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
JPS59167545U (ja) * 1983-04-25 1984-11-09 伊藤 秀雄 中高層建築物用人命救助具
WO2004091596A2 (en) * 2003-04-18 2004-10-28 Pharmacia & Upjohn Company Llc Combination therapies for chronic obstructive pulmonary disease (copd)
CA2795408C (en) 2010-04-12 2018-03-13 Supernus Pharmaceuticals Inc. Methods for producing viloxazine salts and novel polymorphs thereof
CN116848096A (zh) 2021-03-18 2023-10-03 苏佩努斯制药公司 经取代的吗啉的衍生物及其用途
US20230295100A1 (en) 2022-03-18 2023-09-21 Supernus Pharmaceuticals, Inc. Process of making derivatives of substituted morpholines
WO2023248154A1 (en) * 2022-06-22 2023-12-28 Glenmark Life Sciences Limited Process for the preparation of viloxazine hydrochloride
EP4317141A1 (en) 2022-08-04 2024-02-07 Curia Spain S.A.U. Process and intermediates for the preparation of viloxazine and other 2-substituted morpholine derivatives
KR20250094621A (ko) * 2023-12-18 2025-06-25 주식회사 아스트로젠 (s)-빌록사진 또는 이의 염의 개선된 제조 방법

Also Published As

Publication number Publication date
SE393377B (sv) 1977-05-09
YU35009B (en) 1980-06-30
FI61890C (fi) 1982-10-11
HU162422B (en:Method) 1973-02-28
CH539068A (de) 1973-07-15
FI61890B (fi) 1982-06-30
JPS5016795B1 (en:Method) 1975-06-16
YU40208B (en) 1985-08-31
NO135939B (en:Method) 1977-03-21
YU155370A (en) 1979-12-31
ES380973A1 (es) 1973-04-16
YU268978A (en) 1982-10-31
US3712890A (en) 1973-01-23

Similar Documents

Publication Publication Date Title
JPS5016795B1 (en:Method)
AU465452B2 (en:Method)
AU429630B2 (en:Method)
AU450150B2 (en:Method)
CS151027B2 (en:Method)
AU470301B1 (en:Method)
AU438128B2 (en:Method)
AU470661B1 (en:Method)
CS149285B1 (en:Method)
AU5077469A (en:Method)
AU5598769A (en:Method)
CS148364B1 (en:Method)
CS148377B1 (en:Method)
AU4923469A (en:Method)
AU4949169A (en:Method)
AU4540468A (en:Method)
AU5079269A (en:Method)
AU5109569A (en:Method)
AU5133369A (en:Method)
AU5228269A (en:Method)
CS150370B1 (en:Method)
BE733949A (en:Method)
BE60577A (en:Method)
BE739693A (en:Method)
BE743922A (en:Method)